Category: Parkinson’s News

At MDS 2025, the professor of neurology at Northwestern University Feinberg School of Medicine discussed the evolving landscape of disease-modifying clinical trials in Parkinson disease.

More than 35 people with Parkinson’s disease frequent a program called Knock Out Parkinson’s Disease (KOPD) in London, Ont., that has them practice boxing skills in intense workout sessions to delay the progression of the disease.

On this week’s News Voices, WVIA’s Sarah Scinto and Lydia McFarlane discuss Rock Steady Boxing, two gyms in Northeast Pennsylvania that help people with Parkinson’s fight back against the disease’s progression.

The qualitative latest Research report 2025 2032 on the Parkinsons Disease Market by Coherent Market Insights Provides a deep dive into key market trends drivers challenges and the competitive landscape It analyzes market size revenue production and CAGR using validated …

See the stars supporting the cause.

Three years ago, Wes Piatt started the “No Shuffle” class at Coast Range CrossFit in Gilroy.

Parkinson’s patients are receiving a new investigational treatment after a successful study at the University of Wisconsin–Madison helped demonstrate the cell therapy’s safety in non-human primates and refine the method for its delivery. Now, the biotechnology company running the trial is reporting encouraging results. Aspen Neuroscience recently announced they would enroll a third group of patients […]

Liche Zhou, MD, of the department of neurology at Jiang University School of Medicine, provided commentary on new phase 1 data on an iPSC-targeted cell therapy presented at the 2025 MDS Congress.

Deadline: 30-Jan-2026 The Parkinson’s Foundation is currently accepting applications for its Community Grants program, which focuses on supporting local initiatives across the U.S. that improve health, wellness and education for people living with Parkinson’s disease. Eligible applicants include non-profit and other tax-exempt organisations that operate locally and focus on unmet needs in the Parkinson’s disease